Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses

NCT03739775 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT03739775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03739775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses
Lead sponsor
Institut Curie
Phase
Not applicable
Overall status
Completed
Start date
January 24, 2019
Completion date
June 19, 2026
Enrollment
172 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hpv positive pelvic cancer